Conquering Diseases

Extension Of Investigational Drug For Participants Of Centaur Study

Description

This is an extension of a study of the safety and effectiveness of an investigational drug to treat Amyotrophic Lateral Sclerosis (ALS)

Overview

This study is designed to provide longer term access to the new investigational drug to those patients who participated in the another ALS study called CENTAUR study. The study will assess longer term safety and potential of this Investigational drug therapy. The individual components of this drug have been tested in small clinical trials of ALS patients and was found to be safe and well-tolerated, and effective.

What we're hoping for

The purpose of this study is to determine the safety and effectiveness of an Investigational drug that is a fixed combination of two different drugs as a treatment for ALS.

Additional Information

ClinicalTrials.gov Identifier: NCT03127514

 Principal Investigator

Margaret  Owegi, DO

UMass Memorial Health

 Study Contact

Catherine  Douthwright

508-856-6491

Catherine.Douthwright@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989